Genmab — Oktober 2019
-
God morgen
-
City of Hope Leads Phase II Clinical Trial for Efficacy & Safety of ADCT-301 https://www.trialsitenews.com/city-of-hope-leads-phase-ii-clinical-trial-for-efficacy-safety-of-adct-301-in-patients-with-relapsed-or-refractory-hodgkin-lymphoma/
-
teprotumumab...really adds up to a dramatic improvement in that patient’s quality of life. https://www.mdmag.com/conference-coverage/aao-2019/study-teprotumumab-thyroid-eye-disease
-
Undertiden bliver der herinde skrevet om, at “der er en bund under aktien på en eller anden kurs, feks 1400, eller den vil have svært ved at bryde op igennem en eller anden kurs”. Det har jeg endnu ikke set beviser for ! Aktien ter sig nu engang som den har lyst til ?????
-
Vores venner SGEN har en god dag. Lad os glædes over deres succes (+15%) i et fase 3 https://finance.yahoo.com/news/seattle-genetics-announces-positive-topline-104500421.html
-
Jeg kommenterer den aktuelle markedssituation med brexit, handelskrig og en mulig recession forude - samt fortæller om mine forventninger til regnskabssæsonen. Det er på TV2 Business i morgen kl. 7.45.
-
Morn fra Bangkok, Synes umidlbart ikke der er noget alarmerende m.h.t genmab kursudvikling. Set ud fra den stigende trendkannal fra Oktober 2018 ligger vi sådanset meget lunt i svinget og hvis vi forbliver i denne kannal burde vi runde 1500kr anytime mellem Nov. 2019 til April 2020 afhængig hvad vel kursen rykker indenfor kanalen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind